NCT03471793 The Australian Colonic Large Sessile Lesion Endoscopic Resection Study
| NCT ID | NCT03471793 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Western Sydney Local Health District |
| Condition | Colon Adenoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2017-02-24 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2017-02-24 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective, multicentre, observational study of all patients referred for endoscopic resection of sessile colorectal polyps sized ≥20 mm conducted with intention to treat analysis
Eligibility Criteria
Inclusion Criteria: * Patients referred for endoscopic resection of a large sessile colonic polyp or laterally spreading tumour ≥20mm in size. * Able to give informed consent to involvement in the clinical study Exclusion Criteria: * Unable to provide informed consent for involvement
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03471793 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Colon Adenoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03471793 currently recruiting?
Yes, NCT03471793 is actively recruiting participants. Contact the research team at michael@citywestgastro.com.au for enrollment information.
Where is the NCT03471793 trial being conducted?
This trial is being conducted at Westmead, Australia.
Who is sponsoring the NCT03471793 clinical trial?
NCT03471793 is sponsored by Western Sydney Local Health District. The trial plans to enroll 5,000 participants.